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Abstract
The homeodomain transcription factor Nkx2-1 is essential for normal lung development and homeostasis. In lung tumors, it
is considered a lineage survival oncogene and prognostic factor depending on its expression levels. The target genes
directly bound by Nkx2-1, that could be the primary effectors of its functions in the different cellular contexts where it is
expressed, are mostly unknown. In embryonic day 11.5 (E11.5) mouse lung, epithelial cells expressing Nkx2-1 are
predominantly expanding, and in E19.5 prenatal lungs, Nkx2-1-expressing cells are predominantly differentiating in
preparation for birth. To evaluate Nkx2-1 regulated networks in these two cell contexts, we analyzed genome-wide binding
of Nkx2-1 to DNA regulatory regions by chromatin immunoprecipitation followed by tiling array analysis, and intersected
these data to expression data sets. We further determined expression patterns of Nkx2-1 developmental target genes in
human lung tumors and correlated their expression levels to that of endogenous NKX2-1. In these studies we uncovered
differential Nkx2-1 regulated networks in early and late lung development, and a direct function of Nkx2-1 in regulation of
the cell cycle by controlling the expression of proliferation-related genes. New targets, validated in Nkx2-1 shRNA
transduced cell lines, include E2f3, Cyclin B1, Cyclin B2, and c-Met. Expression levels of Nkx2-1 direct target genes identified
in mouse development significantly correlate or anti-correlate to the levels of endogenous NKX2-1 in a dosage-dependent
manner in multiple human lung tumor expression data sets, supporting alternative roles for Nkx2-1 as a transcriptional
activator or repressor, and direct regulator of cell cycle progression in development and tumors.
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Introduction
Lineage-specific transcription factors play master roles in
development and in maintenance of particular phenotypes in
normal tissues and in disease [1]. NK2 homeobox 1 (Nkx2-1,
Nkx2.1, Ttf-1, Titf1, T/ebp) is a transcription factor necessary for
normal lung, thyroid and brain development [2]. In the lung, once
the respiratory epithelial cell fate is established, Nkx2-1 partici-
pates in expansion and differentiation of epithelial progenitor cells
to form the lung branches; later in development, its expression is
restricted to a subset of bronchiolar and alveolar epithelial cells,
where it contributes to maintain their normal phenotype. In
tumors, variable levels of NKX2-1 expression are detected in 40–
50% of non-small cell lung carcinomas (NSCLCs), being higher in
lung adenocarcinomas than in squamous cell carcinomas,
suggesting that levels of NKX2-1 expression are linked to tumor
cell phenotypes [3,4].
Previous studies showed the physiological importance of normal
Nkx2-1 expression levels in development and its dysregulation in
disease. In mouse lung, Nkx2-1 absence results in impaired
branching morphogenesis, abnormal distal cell differentiation and
neonatal death [5]; mutations that prevent Nkx2-1 phosphoryla-
tion result in relatively normal morphogenesis but lethal functional
defects [6]; conversely, epithelial Nkx2-1 over-expression produces
cell hyperplasia, disrupted alveolar septation and emphysema [7].
In human lung, NKX2-1 haplo-insufficiency causes respiratory
dysfunction, abnormal airway and alveolar morphogenesis,
abnormal surfactant protein expression and infections [2,8]. In
lung cancer, NKX2-1 has been proposed as a positive or negative
prognostic factor depending on expression levels [3,4]. Amplifica-
tion of the 14q13 locus containing the NKX2-1 gene is observed in
only 11–15% of adenocarcinomas [3,9,10]; DNA mutations in the
open reading frame that may produce a mutated protein or
truncations are rarely encountered [3,10].
The functions elicited by Nkx2-1 expression in different cell
contexts are primarily determined by the direct target genes
transcriptionally regulated by Nkx2-1. In the lung, a few Nkx2-1
direct target genes have been identified by individual gene
promoter analyses including surfactant proteins, secretoglobins,
ABCA3 and Nkx2-1 itself [11]. Microarray expression analyses
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29907identified genes directly and indirectly regulated by the active
phosphorylated form of Nkx2-1 in mice [6] and in human lung
fetal cells [12]. The transcriptional program directly controlled by
Nkx2-1 in early and late mouse lung development [11] that may
explain its primary developmental effects, and the genes regulated
by NKX2-1 in human lung cancer are unknown [2,3].
To address these issues we have analyzed, by chromatin
immunoprecipitation-chip and intersection with expression data
sets, direct in vivo Nkx2-1 transcriptional targets in early vs. late
lung development. The genes identified may serve as primary
effectors of Nkx2-1 functions in different developmental cell
contexts. We determined expression levels of Nkx2-1 target genes
identified in development and correlated their expression to the
level of NKX2-1 in more than ten public human lung tumor data
sets. The regulatory networks discovered clarify the diverse
biological roles of Nkx2-1 observed in development, and provide
a rationale for the association of NKX2-1 levels and NSCLCs
prognosis via its downstream targets.
Results
Selection of lung developmental stages for Nkx2-1 target
analysis
To identify genes directly regulated by Nkx2-1 in different cell
contexts during lung development we selected two developmental
stages based on general differentiation characteristics of the
epithelium, and Nkx2-1 expression patterns [13]. We analyzed
Nkx2-1 target genes at E11.5, when Nkx2-1 is expressed in most
epithelial cells as lung buds start branching (Figures 1A, 1C, and
1E) and at E19.5, when Nkx2-1-expressing cells in the distal lung
are undergoing extensive differentiation preparing for the first
breath at birth (Figures 1B, 1D and 1F). We observed, by confocal
microscopy, using either the rabbit monoclonal Nkx2-1antibody
(Figures 1A–D, ab76013; Abcam) or the rabbit polyclonal Nkx2-1
antibody (Figures 1E,F, 07-601; Millipore-Upstate), that Nkx2-1
and the proliferation marker Ki67 [14] co-localize in most
epithelial nuclei at E11.5 (Figure 1C, .90%; n=3, and
Figure 1. Spatial and temporal pattern of Nkx2-1 protein expression in developing mouse lung. Immunohistochemistry analyses of
Nkx2-1 protein expression using the Nkx2-1 antibody (ab76013) in (A) E11.5 lung (bar=100 mm)) and in (B) E19.5 lung (bar=100 mm). Nkx2-1 is
expressed in all lung epithelial cells at E11.5, but is restricted to bronchiolar and type II alveolar cells at E19.5. Confocal immunofluorescence co-
localization analysis of Nkx2-1 (green) and Ki67 (red) proteins in (C) E11.5 (bar=20 mm) and (D) E19.5 embryonic lung (bar=20 mm) using the Nkx2-1
antibody (ab76013) and in (E) E11.5 (bar=20 mm) and (F) E19.5 embryonic lung (bar=20 mm) using the Nkx2-1 antibody (07-601). Nkx2-1 and Ki67 co-
localized in most epithelial nuclei at E11.5 (C,E inserts) but are detected in different cells at E19.5 (D,F inserts). (G) Western blot analysis of Nkx2-1
protein expression using Nkx2-1 rabbit polyclonal antibody (07-601) in developing mouse lung at the indicated time points, and adult lung, thyroid
and liver. MLE15 mouse epithelial cells and H441 human lung carcinoma cells were also analyzed. Actin was used as control. Two main bands
between 40 and 50 kD are detected with a differential developmental pattern of expression (n=3) (black arrows). Other minor bands of unknown
identity are also detected (*) Lb (lung buds), V (blood vessels), Br (bronchioles), E (epithelium), M (mesenchyme), A (alveolus), green arrow.
doi:10.1371/journal.pone.0029907.g001
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distal lung express Ki67, and those cells do not express Nkx2-1
protein (Figure 1D, 1F and inserts). The monoclonal antibody
detects nuclear Nkx2-1 protein expression while the polyclonal
antibody detects signal both in the nucleus and cytoplasm.
Detection of Nkx2-1 in the cytoplasm has been previously shown
by other authors [15,16,17]. These results indicate that lung
epithelial cells expressing Nkx2-1 in early and late lung
development go through different biological processes; it is likely
that Nkx2-1 elicits different functions by binding to specific target
genes in these developmental stages. Context specific gene
regulation controlled by Nkx2-1 has been shown in early and
late brain development [13,18,19,20], where Nkx2-1 regulates the
specification of interneuron subtype in early proliferating telence-
phalic progenitors, and later, the migration and sorting of post
mitotic neurons to different regions of the brain.
We also characterized, by western blots, Nkx2-1 protein
expression patterns at different mouse lung developmental stages,
thyroid, liver, and mouse MLE15 and human H441 cell lines.
Using the rabbit polyclonal Nkx2-1 antibody (Millipore-Upstate),
the same antibody used in ChIP assays, we detected two major
bands between 40 and 50 kD in E13.5, E19.5, and adult lung, and
in the MLE15 lung epithelial cell line. The higher molecular
weight or lower mobility band was the major band detected at
E11.5. Its abundance was increased from E13.5 to E19.5
consistent with previous reports [12,21] (Figure 1G). Only one
band corresponding to the lower mobility protein was detected in
mouse thyroid and in the H441 human lung carcinoma cell line
although their mobility is not identical. Two mouse Nkx2-1
transcripts (2.1 kb and 2.3 kb) differentially expressed during lung
development [21] are translated in vitro into two proteins that
share a common DNA binding domain but differ in their N-
terminal domain. The function and regulation of these isoforms in
lung development are unknown, although they differentially
activate the surfactant protein C (Sftpc) promoter [12,21]. Also
Nkx2-1 posttranslational modifications such as phosphorylation,
acetylation and redox state can modify Nkx2-1 proteins altering
their molecular weight, mobility in electrophoresis assays and
transcriptional activity [17,22]; the lack of specific antibodies for
each isoform or posttranslational modification precludes evaluat-
ing them in the present studies.
Genome-wide analysis of Nkx2-1 target genes in lung
development
Due to the differential pattern of Nkx2-1 protein expression,
and proliferation state of expressing cells in E11.5 and E19.5 lung,
we chose these developmental time points to identify genome-wide
Nkx2-1 binding to target genes in vivo. Chromatin immunopre-
cipitation (ChIP) assays, ligation mediated-PCR (LM-PCR)
amplification, and hybridization to promoter tiling arrays were
performed to map Nkx2-1 genomic occupancy [23,24,25]. Nkx2-1
binding patterns on all mouse chromosomes (Supplementary
Figure S1) at E11.5 and E19.5 showed comparable binding levels,
despite the different cell context compared. The complete data set
is available at GEO (GSE23043).
Bioinformatic analysis of the ChIP-chip data allowed us
identifying unique interactions between Nkx2-1 and genomic
DNA regions at high confidence. Nkx2-1 binds to ,8,000
features/oligonucleotides on the promoter tiling arrays at E11.5,
and ,9,000 at E19.5 (p,0.001). Multiple features correspond to
regulatory regions on the same gene. Comparison of Nkx2-1
binding features revealed that 25% of the targets were unique to
E11.5 (3010 features), 32% were unique to E19.5 (3934 features)
and 43% (5170 features) were common to both developmental
stages. The Nkx2-1 bound features/oligonucleotides correspond to
regulatory regions of .1300 independent genes at E11.5 and at
E19.5 of the ,17,000 represented in the array (Supplementary
Table S1a and S1b). Comparison of common bound genes using
the ,1300 highest bound single probes representing individual
genes showed that only 85 of the ,1300 genes (6.5%) were
common between E11.5 and E19.5. These findings suggest that
most of the common probes found at both time points have
significant but low binding signal. So most of the genes used in
further studies were either highly bound at E11.5 or at E19.5.
We found Nkx2-1 protein bound to its own promoter, the
promoters of surfactant proteins-A and –B (Sftpa, Sftpb),
secretoglobin 1a1 (Scgb1a1) consistent with previous reports [2]
(Figure 2A) and other targets (Figure 2B). By intersecting the
ChIP-chip data and microarray expression data sets of mesen-
chyme-free freshly isolated E11.5 lung epithelium [26] we
identified Nkx2-1 target genes expressed in E11.5 lung. Among
3154 genes called ‘present’ in E11.5 lung epithelium, 374 genes
are Nkx2-1 targets (p#0.001) (Supplementary Table S2). Of the
2611 genes called ‘present’ in a public E18 lung data set [27], 183
genes are Nkx2-1 targets at E19.5 (#0.001) (Supplementary Table
S2). Furthermore, ,50% of the 95 top genes regulated by Nkx2-1
in human fetal epithelial cells are direct targets of Nkx2-1
(Supplementary Table S3), validating our findings.
Validation of selected ChIP-chip targets by ChIP and
gene specific PCR
We confirmed in vivo binding of Nkx2-1 to selected ChIP-chip
predicted targets involved in cell proliferation by gene-specific
ChIP-PCR in E11.5 and E19.5 lung (Figure 2C) using the same
antibody than in the ChIP-chip analyses; we validated them as
bona fide direct targets of Nkx2-1. Nkx2-1 regulated genes in
other organs such as thyroglobulin in thyroid or Lhx6 and Olig3
in brain, not detected in lung development, are highly bound by
Nkx2-1 in the lung (Supplementary Figure S2), indicating that
binding does not imply functional activation of transcription;
other mechanisms, such as chromatin remodeling or DNA
methylation, may silence those genes in the lung. Genes
expressed later in lung development are already bound by
Nkx2-1 at E11.5. For example, Sftpa, not expressed at detectable
levels in E11.5 lung, is bound by Nkx2-1 in regions 59 and 39 to
the transcription initiation site (Figure 2A). At E19.5, increased
Nkx2-1 binding is detected on the Sftpa promoter region
correlating with higher transcription as previously described by
classical promoter analyses [28].
Biological processes and pathways targeted by Nkx2-1
To identify novel genes and pathways that may be effectors of
Nkx2-1 functions during lung development, we performed Gene
Ontology analyses using EASE [29] and ,1300 individual genes
bound by Nkx2-1 (log2 binding ratio .0.75; p#0.001) at E11.5
or at E19.5. These analyses revealed significant enrichment in
many biological processes at each time point (p,0.05) (Supple-
mentary Table S4). Selected genes in the top biological processes
at each time point are shown in Table 1. In particular, ‘positive
regulation of cell proliferation’ is significantly enriched at E11.5
(p=0.0038) but not at E19.5 (p=0.9824), while ‘ion transport’ is
enriched at E19.5 (p=0.0001) but not at E11.5 (p=0.1976),
supporting a differential role for Nkx2-1 at each developmental
stage [30]. We concentrated our studies in Nkx2-1 proliferation-
related target genes because of their link to development and
cancer. Although Nkx2-1 has been shown to control cell
proliferation [7,10], direct regulation of proliferation-related
genes by Nkx2-1 has not been reported. Proliferation-related
Nkx2-1 Target Genes in Alternative Cell Contexts
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e29907Nkx2-1-target genes expressed in early lung epithelium and/or
human lung tumors are shown in Table 2. Overrepresented
pathway analysis performed by Ingenuity Pathway Analysis at
E11.5 and E19.5 (Supplementary Table S5) identified common
Nkx2-1 targeted pathways at both stages, such as ‘mechanisms of
cancer’ and ‘HGF signaling’ (Supplementary Table S6). Other
pathways were uniquely overrepresented at E11.5, including
‘RAR signaling’ and ‘TR/RXR activation’, and at E19.5,
including ‘renin-angiotensin signaling’. These Nkx2-1 regulated
pathways have been previously linked to lung development and
tumorigenesis [31,32,33].
Reduced Nkx2-1 expression affects cell cycle progression
and transcription of target genes
To evaluate whether altered levels of Nkx2-1 expression can
affect target gene transcription, we performed short hairpin RNA
(shRNA)-mediated Nkx2-1 knockdown in the mouse lung
epithelial cell line MLE-15. These cells express both forms of
the Nkx2-1 protein identified in development (Figure 3A). Nkx2-1
message was reduced by 60% and average expression of both
Nkx2-1 protein forms was reduced by 40% (Figures 3A and D).
Nkx2-1s shRNA reduces expression of the two main bands
between 40–50 kD but also of a faint band of higher molecular
weight. These bands may represent modifications of Nkx2-1,
although we have not confirmed their composition. Reduction of
Nkx2-1 delayed cell cycle progression by halting cells in G2/M
phase (Figures 3B and C). The moderate reduction in Nkx2-1
levels has a measurable impact on cell growth and target gene
regulation. Cell count analyses performed at 24 h intervals for 4
days show a significant difference in total number of cells after 3
days in culture (Figure 3D). By qRT-PCR we determined
downregulation of E2f3, Ccnb1, Ccnb2, and Pik3ca by reduction
of Nkx2-1 (Figure 3E). Block of cell cycle in G2/S phase observed
by down-regulation of Nkx2-1 in cell lines may be mediated by
down-regulation of Cnnb1 and Cnnb2 which participate in
transition of cells into the synthesis phase. c-Met, conversely,
was highly upregulated, supporting a role of Nkx2-1 as a
transcriptional repressor. Alternatively, indirect mechanisms
controlled by Nkx2-1, besides Nkx2-1 binding to c-Met promoter,
could control transcription of this gene.
Figure 2. Nkx2-1 binding patterns to selected target genes in lung development. (A) Binding patterns of Nkx2-1 to known lung target
genes. Binding ratios (IP/Input) are shown at different chromosomal locations. Pink (binding in E11.5 lung), blue (binding in E19.5 lung). Transcripts
are indicated by a black line. (B) Binding patterns of Nkx2-1 to newly identified targets involved in cell proliferation. (C) Chromatin
immunoprecipitation-PCR validation of Nkx2-1 binding to proliferation-related target genes. Nkx2-1 IP DNA from E11.5 and E19.5 lungs, Input and
IgG immunoprecipated control were used in PCR analyses. Oligonucleotides in the promoter region were used to analyze binding of Nkx2-1, and at
exon regions of the same gene as control, (n=2).
doi:10.1371/journal.pone.0029907.g002
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expression levels in NSCLC
Lung development and cancer have been linked by comparing
embryonic and tumor gene expression profiles [34,35]. Also,
developmental gene programs active in human lung tumors have
been explored as predictors of patient’s survival [35,36]. The
effector genes responsible for these associations, however, are
largely unknown. We evaluated expression of Nkx2-1 target genes
identified in mouse development in human lung tumors, and
their correlation with endogenous NKX2-1 levels (Figures 4 and
S4). Sixteen human lung tumor data sets, available in GEO or
the literature, including gene expression levels in lung adenocar-
cinomas and squamous cell carcinomas, were analyzed (Table 3).
Human homologues corresponding to mouse Nkx2-1 target genes
at E11.5 (350 genes) and at E19.5 (183 genes) were used in GSEA
analyses. The expression of E11.5 developmental target genes
significantly correlated or anti-correlated to NKX2-1 level in 10
out 16 data sets (p,0.05). The expression of E19.5 developmen-
tal target genes significantly correlated or anti- correlated to
NKX2-1 level in 9 out 16 data sets (p,0.05). The anti-correlation
of many Nkx2-1 target genes with NKX2-1 expression in tumors
(Figures 4 and S4) and of c-Met with Nkx2-1 levels shown in
MLE15 cells supports a role of Nkx2-1 as a transcriptional
repressor.
We also determined the enrichment of particular biological
processes within the expression/correlation groups (Table 4). In
the lung tumor datasets evaluated, there is a negative correlation
between NKX2-1 and regulators of the cell cycle identified in early
development, while there is a positive correlation with genes
involved in transcriptional regulation. These links might be helpful
in understanding the fact that patients with adenocarcinomas with
higher levels of NKX2-1 expression have a better prognosis than
those with lower or no expression of NKX2-1. For example, we
determined that higher levels of NKX2-1 expression correlate to
lower level of expression of the target genes Ccnb1, Ccnb2, Cdc2,
Cdkn2c, and Mcm2.
Discussion
To identify direct transcriptional targets of Nkx2-1 that could be
effectors of its developmental functions we performed ChIP-chip
analyses in early and late developing mouse lung. The differential
expression pattern of Nkx2-1 at these developmental stages
allowed us to evaluate Nkx2-1 targets in cell populations
undergoing proliferation at E11.5 and differentiation at E19.5.
In this work, we identified a preferential role for Nkx2-1 in direct
transcriptional regulation of proliferation-related genes in early
development and of ion transport genes in late development.
Nkx2-1 regulation of lung cell proliferation and survival was
previously shown in development and tumor cell lines [3,7,9], but
the effector genes directly regulated by Nkx2-1 were largely
unknown. Amongst several proliferation-related genes targeted by
Nkx2-1, we identified E2f3, cyclins Ccnb1 and Ccnb2, and c-Met.
E2f3 controls the rate of cell proliferation by controlling the G1/S
transition and the initiation of DNA synthesis [37,38] and is
expressed in the lung epithelium in early development [39,40].
Cyclins Ccnb1 and Ccnb2 regulate the G2/M phase transition
and are ubiquitously expressed in the lung during development.
Ccnb1, E2f3 and other proliferation genes are mostly bound by
Nkx2-1 at E11.5 but not at E19.5. Binding of Nkx2-1 to the
promoters of these genes correlates with increased expression
(Figure S3), and with proliferative state of the epithelial cells in
early lung development. c-Met is a proto-oncogene and the HGF
receptor tyrosine kinase expressed in E13 mouse lung epithelium
and thereafter, where it is involved in mitosis, migration and
morphogenesis [41]. Reduction of Nkx2-1 expression in cell lines
alters expression of these genes, and slows down cell cycle
progression. In vivo, the absence of Nkx2-1 results in impaired
lung epithelial lineage expansion and branching morphogenesis.
These findings make us speculate that reduced expression of genes
involved in cell proliferation and progression of the cell cycle may
contribute to the hypomorphic lung phenotype observed in Nkx2-
1 null embryos [5,42,43]. It will be interesting in the future to
determine if altered expression of the genes identified precludes
Table 1. Selected genes in non-redundant over-represented biological processes among genes bound by Nkx2-1.
E11.5
Term PValue Genes
Positive regulation of cell proliferation 3.77E-03 Odc1, Il3, Cdca7l, Prkcq, Notch1, Myc, Il12a, Recql4, Lig4, Nr2e1, Cnbp, Bcl2, Hcls1,
Igf1, E2f3, St8sia1, Lamb1-1, Il4, Otp, Nodal, Il18, Cd3e, Ube2c, Edg3, Sp6,
Ras protein signal transduction 5.56E-03 Arhgef11, Arf6, Tbc1d20, D10Ertd610e, Fgd3, Rhob, Rasgrf2, Psd4, Arhgdia,
D10Bwg1379e, Hrasls, Psd3, Fgd2, Nisch, Cdc42ep4, Hras1, Grit, Rasgrp3, Tbc1d10a,
Pscd3, Rfxank, Abr, Plce1, Tbc1d2b,
E19.5
Term PValue Genes
Ion transport 9.77E-05 C1qtnf3, Steap4, Bat3, Atp6v1g3, Kcne3, Slc41a2, Cacnb4, Col1a1, Kcnc2, Grid1, Itpr2,
Pkd1, Slc39a11, Clca5, Atp6ap1, Kcnn2, Steap1, Slc6a8, Kcnv1, Kcnj8, Slco2b1, Kcnj16,
Kcne2, Slc4a4, Kcnk9, Slc12a5, Slc34a1, Slc38a2, Tigd4, C1qtnf7, Cybb, Accn2, Gabra3,
Slc13a1, Col8a1, Kctd13, Slc9a7, Slc11a1, Kcnh5, Kcnmb4, Fxyd3, Atp13a1, Rcvrn, Myb,
Clcn1, Chrna1, P2rx1, Slc5a3, Kcnj15, Slc22a6, Sfxn4, P2rx7, Col6a2, Slc26a1, Adrb2,
Stim1, Slc34a2, C1qa, Slc22a4, Ank, Rhbg, Kcnc4, Gm414, Fxyd2, Col17a1, Chrna7,
Slc17a1, Clic5, Atp1a1, Steap3, Slc41a1, Slc12a8, Slc30a6, Col4a6, Kcne4, Kctd4, Sftpa1,
C1qtnf5, Slc39a14, Atp6ap2, Atp2b3,
Response to wounding 4.67E-03 Saa3, Thbs1, Daf2, Tlr11, Tollip, Il17d, F7, AI182371, Cxcl10, C8a, F9, Ccl22, Ccl5, C4bp,
Nfam1, Stab1, C1qa, Sod1, C8b, Fga, Ly86, Abhd2, S100b, Chrna7, F2rl3, Alox5, Chi3l3,
Cd28, Serpinf2, Casp3, Pap, Il6, Tac1, Cd24a, F10,
doi:10.1371/journal.pone.0029907.t001
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GeneName SystematicName Description Signal p value
Lung
Expression
E11.5 (Lu
et al 2005)
E14.5
(GenePaint) Tumors PMID
Ube2c chr2:164463527-
164463586
INSIDE 1.904 1.37E-20 P E/M lung tumors 15208666
Fkbp1a chr2:151229364-
151229423
PROMOTER 1.842 3.08E-22 P E metastasis 11517338
Erbb3 chr10:127991654-
127991713
INSIDE 1.649 2.85E-09 P E NSCLC 12483526
Tff1 chr17:030889902-
030889950
INSIDE 1.536 1.85E-13 P e adenocarcinoma 7917539
Map3k11 chr19:005690697-
005690741
INSIDE 1.503 1.32E-18 P e/M solid tumors (lung) 18636107
Pik3ca chr3:032629205-
032629264
INSIDE 1.412 2.30E-18 A e lung tumors 19010912
Anln chr9:022081918-
022081977
DOWNSTREAM 1.330 2.67E-21 P E/M SCC 16357138
Rhob chr12:008528273-
008528332
PROMOTER 1.311 5.97E-21 P E/M lung tumors 15102679
Ncaph chr2:126823595-
126823654
INSIDE 1.301 3.06E-11 P NA
E2F3 chr13:029996944-
029997003
PROMOTER 1.270 2.07E-07 A E NSCLC/sclc 16938365
Ccnb1 chr13:101891449-
101891508
PROMOTER 1.253 7.30E-13 P E/m NSCLC 12883711
Fgfr3 chr5:034037899-
034037943
PROMOTER 1.215 1.20E-19 P E/m NSCLC 17949785
Sox4 chr13:028964510-
028964569
PROMOTER 1.209 2.98E-05 P E lung tumors 19153074
Odc1 chr12:017565992-
017566050
PROMOTER 1.145 6.20E-07 P E/M NSCLC 20199977
Cdca7l chr12:118283635-
118283694
PROMOTER 1.143 1.64E-14 P E
Asns chr6:007647542-
007647601
PROMOTER 1.093 1.58E-04 P E
Racgap1 chr15:099483295-
099483350
PROMOTER 1.090 2.00E-19 P E/M
Hras1 chr7:141042582-
141042630
DOWNSTREAM 1.049 3.30E-08 P E NSCLC 10430091
Ptprf chr4:117777704-
117777758
INSIDE 1.026 7.95E-14 P NA
Msh2 chr17:087582981-
087583033
INSIDE 0.997 4.92E-18 P E NSCLC 18646042
Pard3 chr8:130324465-
130324524
INSIDE 0.976 6.74E-05 P E/M Tumors 20215515
Erh chr12:081561122-
081561181
INSIDE 0.973 2.04E-13 P E/M Breast cancer 18500978
Nek6 chr2:038335233-
038335289
INSIDE 0.968 1.30E-04 P E lung tumors 20407017
Cdkn2c chr4:109162876-
109162934
INSIDE 0.946 2.11E-10 P ND mouse lung tumors 17409423
Prdx1 chr4:116184956-
116185015
INSIDE 0.930 9.83E-05 P E/m NSCLC 18413821
Mfge8 chr7:079028025-
079028075
PROMOTER 0.926 6.20E-06 P E/M
Furin chr7:080274016-
080274066
INSIDE 0.916 5.15E-13 P E/m
Bcl2 chr1:108538280-
108538339
INSIDE 0.915 6.31E-05 P E/M NSCLC 19240654
Cnbp chr6:087818676-
087818735
PROMOTER 0.902 1.68E-11 P E/M NSCLC 17327219
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the process of branching morphogenesis.
A different context is observed at E19.5, when Nkx2-1
expressing cells are differentiating and preparing for the rapid
absorption of luminal fluid and for the first breath [44,45]. Nkx2-1
binding to ion transport genes in distal lung epithelial cells at
E19.5 suggests that Nkx2-1 participates in differentiation of the
distal lung epithelium to perform these functions at birth. Gene
expression analyses of E18 lungs harboring a Nkx2-1 phosphor-
ylation-deficient mutant also show reduced expression of genes
that regulate fluid and electrolyte transport [6] supporting a direct
link between Nkx2-1 and these functions.
Our results may also have important implications for under-
standing NKX2-1 functions in lung cancer. A link between
development and tumorigenesis has been suggested in different
cancers and their corresponding organ of origin [34]. Genomic
associations between human lung cancer subtypes and developing
mouse lung indicated that tumors with genomic profiles similar to
early lung development correlate to poorer patient’s prognosis [35]
while tumors with gene expression profiles similar to more
differentiated lung cell phenotypes correlate to better patient’s
prognosis. Developmental genes expressed in tumors, such as
NKX2-1 may underlie these associations. Multiple evidences
support a dual role for NKX2-1 as a proto-oncogene and tumor
suppressor gene in lung cancer. NKX2-1 is considered a lineage
specific oncogene since its expression is increased or amplified in
some lung tumors [3,9,46,47]. In other analyses NKX2-1 is
considered a good prognostic factor, since patients with NSCLC
showing high levels of NKX2-1 or amplification of the locus have
a better prognosis than those that have lost NKX2-1 expression
[10,48]. NKX2-1 was also proposed as a suppressor of lung
adenocarcinoma progression in a mouse model of lung cancer
[49]. NKX2-1 target genes, effectors of these functions in lung
tumors are also unknown. NKX2-1 and some human homologues
of the targets identified in development, including E2F3, CCNB1,
CCNB2 and c-MET have been proposed as independent lung
tumor markers and prognostic genes. E2F3 is overexpressed in 55–
70% squamous cell carcinomas and 79% of adenocarcinomas of
the lung. [50], and is associated with high Ki67 in invasive cancers
[51]. Increased expression of CCNB1 in NSCLC was suggested as
a poor prognostic parameter [52,53,54]. CCNB2 and c-MET are
also over expressed in adenocarcinomas [55,56,57,58]. Our
findings point to NKX2-1 as a direct transcriptional regulator of
these independent markers of lung tumorigenesis modulating their
level of expression at different stages of tumor progression.
Comparison of mouse lung development and human lung
cancer data sets identified cell cycle and proliferation as the largest
gene categories involved in both processes. Since early develop-
ment in most organs involves significant cell proliferation, it is not
surprising that most similarities between NKX2-1 targets in early
lung development and tumors are related to cell cycle and
proliferation genes [59]. It is possible that tumor cells maintaining
lung-lineage characteristics use tissue/cell specific factors including
NKX2-1 to control proliferation and other functions. In addition
to the genes identified in these studies, there may be other genes
uniquely regulated by NKX2-1 in tumors and not in development;
to identify those genes it will be necessary, in the future, to analyze
direct NKX2-1 binding in primary tumors or alternatively in
tumor cell lines.
It is intriguing that many cell proliferation genes inversely
correlate to the levels of NKX2-1 in NSCLC. This inverse
correlation may explain the poorer prognosis of patients with
NSCLC with low levels of NKX2-1. To determine if the reverse
correlation is due to repression by direct NKX2-1 binding, ChIP
analyses may be performed in human tumor tissues or tumor cell
lines. Alternatively molecular analyses of the promoters of these
genes in cell lines may provide information about the repression of
these genes by Nkx2-1 binding. These experiments will be the
focus of our future studies. Adenocarcinomas sub-classification
based on gene expression profiling was proposed to improve
prediction of malignant potential and prognosis [35]. The
associations identified in our studies may contribute to the
molecular classification of these tumors and clarify NSCLC
heterogeneity, holding great potential to increase the understand-
ing of this disease.
Our findings point to potential molecular mechanisms by which
Nkx2-1 may differentially regulate transcriptional activity. First,
inverse correlation in expression level of NKX2-1 and targets in
tumors, and of Nkx2-1 and c-Met in MLE15 cells suggests a more
widespread role of Nkx2-1 in transcriptional repression. This effect
GeneName SystematicName Description Signal p value
Lung
Expression
E11.5 (Lu
et al 2005)
E14.5
(GenePaint) Tumors PMID
Notch1 chr2:026326836-
026326885
PROMOTER 0.902 2.47E-04 P E NSCLCs 20007775
Pawr chr10:107733486-
107733545
PROMOTER 0.894 3.17E-10 P E lung tumors 18650932
Hmox1 chr8:077991770-
077991828
INSIDE 0.892 1.17E-12 P ND adenocarcinoma 15688187
Igf2 chr7:142465948-
142466003
INSIDE 0.892 1.74E-13 P E adenocarcinoma 11536368
Mmp14 chr14:053385520-
053385574
PROMOTER 0.884 1.63E-08 P E/M SCC 15036884
Ccnb2 chr9:070223337-
070223396
PROMOTER 0.812 1.32E-15 P e/m NSCLC 15331390
E, high expression in lung epithelium; e, low expression, M, high expression in lung mesenchyme; m, low expression; ND, non-detected;
NA, non-available; P, present; A, absent.
doi:10.1371/journal.pone.0029907.t002
Table 2. Continued.
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activation of transcriptional repressors by Nkx2-1 to down-
regulate particular genes. Nkx2-1 has been mostly linked to
transcriptional activation in lung and other organs [2], although
neuropilin-2 [20] and RAGE [60] have been reported to be down-
regulated by direct binding of Nkx2-1 to a cis-element in their
promoters strongly supporting Nkx2-1 repressor activity.
Second, there are target genes bound by Nkx2-1 at both
developmental time points, whereas others are bound only at
E11.5 or E19.5. Interactions with alternative co-factors differen-
tially expressed at each time point might result in differential
affinity and binding to alternative targets [21]. Different isoforms
and/or modifications of Nkx2-1 proteins by phosphorylation,
acetylation or oxidation may affect affinity for particular cis-
elements or interactions to different co-factors at each time point
[17,22,61]. Identification of different forms of Nkx2-1 protein at
E11.5 and E19.5 will be necessary to fully understand the different
targets in alternative cell contexts.
The specificity of Nkx2-1 binding has also been linked to
promoter structure [62]. Differences in chromatin modifications
surrounding these cis-elements in different cell contexts could affect
affinity of Nkx2-1 proteins. For example binding of Nkx2-1 to the
Sftpb promoter is prevented by DNA methylation of the Sftpb
promoter in non-expressing tissues, such as thyroid [63]. To fully
understand the differences in binding patterns in different cell
contexts we will need to identify the consensus sequences and the
chromatin modifications of the binding sites in genomic regions
only bound at E11.5 or only bound at E19.5. Future analyses will
be focused in discerning these alternatives and characterizing
Nkx2-1 binding sites in different contexts.
Finally, we observed strong binding to brain and thyroid genes
not expressed at detectable levels in developing lung, suggesting
Figure 3. Downregulation of Nkx2-1 affects expression of proliferation-related genes in mouse lung epithelial cells. (A) Western blot
analysis of Nkx2-1 downregulation by shRNA in MLE15 cells using the Nkx2-1 antibody 07-601 (Millipore-Upstate). Two bands between 40–50 kD are
detected in mouse MLE15 cells and E17.5 lung. Densitometry analyses show a significant downregulation of Nkx2-1 major bands in shRNA
transduced cells. Nkx2-1 downregulation by shRNA also reduces the level of minor bands of higher molecular weight (*, asterisks) (B) Representative
flow cytometry analyses of DNA content and cell cycle progression in the same cells; n=3. (C) Relative number of cells in each stage of the cell cycle.
(D) Cell count analysis of MLE15 cells transduced with empty vector or Nkx2-1shRNA. 5000 cells were plated and grown in standard conditions for up
to 4 days. Attached cells were trypzinized and counted; n=6 (E) Real time RT-PCR analyses of Nkx2-1 mRNA expression levels in Nkx2-1 shRNA or
empty vector transduced cells; n=3; similar analyses were performed for selected targets; n=6. Error bars represent s.e.m.; (*) p#0.05.
doi:10.1371/journal.pone.0029907.g003
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In certain cases, binding may precede activation such as in the
case of Sftpa and may prime the gene for activation upon
recruitment of other transcription complexes and/or co-factors to
the promoter. The identification of unique Nkx2-1 targets at
E11.5 and E19.5 will facilitate the evaluation of possible
mechanisms that control specificity.
Overall, we provide novel insights into biological processes
regulated by Nkx2-1 in different cell contexts in development, and
cancer. We identified Nkx2-1 direct target genes in mouse lung
epithelium that are primary effectors of Nkx2-1 functions, in
particular cell proliferation genes. We showed that expression levels
of the target genes depend on NKX2-1 levels in NSCLC. NKX2-1
has been associated to longer, similar or shorter patient survival in
NSCLC, depending on expression levels [10,64]. Therefore,
evaluation of NKX2-1 expression levels relative to its downstream
targets will provide a way to sub-classify NSCLCs, and understand
the mechanisms underlying associations to patient survival.
Materials and Methods
Antibodies
A rabbit polyclonal Nkx2-1 antibody (EMD-Millipore-Upstate
07-601) was used in ChIP assays, immunofluorescence analyses
and western blots; a rabbit monoclonal Nkx2-1 antibody (Abcam,
ab76013) was used in immunofluorescence analyses and western
Figure 4. NKX2-1 levels in human lung tumors significantly correlate with expression of developmental Nkx2-1 target genes.
Heatmaps of human lung tumor genes identified in GSE12667 database showing gene expression levels of the human homologues of Nkx2-1 target
genes identified in mouse lung development at E11.5 (upper panel) and E19.5 (lower panel); genes are organized according to their Pearson
correlation value (y axis) to relative NKX2-1 expression level (x axis).
doi:10.1371/journal.pone.0029907.g004
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tested. Although some antibodies work well in experiments such as
western blots, or immunocytochemistry, they may not necessarily
work in ChIP assays since the fixative conditions used may mask or
destroy some epitopes. Monoclonal antibodies, such as ab76013,
have higher specificity than polyclonal sera, but polyclonal sera,
such as 07-601, may recognize several epitopes of the target,
increasing signal levels [65,66].
We selected the rabbit polyclonal Nkx2-1 antibody for the ChIP-
chip analyses based on our previous results [63] and additional
experiments performed for this manuscript. We have previously
shownspecificityofthisantibodyinChIP-PCRanalysesinvitroand
in vivo. Briefly MLE15 cells were transfected with a wild type or
mutant Sftpb promoter construct containing mutations of four
Nkx2-1 consensus sites. ChIP-PCR assays were performed with the
rabbit polyclonal Nkx2-1 antibody or IgG. Mutation of the Nkx2-1
binding sites abolished binding of Nkx2-1 to the promoter and
therefore no PCR band is observed when the mutant DNA is
immunoprecipitated with the Nkx2-1 antibody. PCR with oligo-
nucleotides in the b-actin locus were also used to indicate the
absence of non-specific binding. In addition we showed using the
same antibodythat Nkx2-1 binds tothe endogenousSftpb promoter
in the lung but not the thyroid where the DNA in this region is
highly methylated. This same antibody shows binding of Nkx2-1 to
the thyroglobulin gene promoter in both tissues but not to b-actin.
Supporting experiments that show the specificity of the antibodyare
included in the results section where down regulation of Nkx2-1
gene expression by shRNAs results in reduction in intensity of the
twomajorbandsinWesternblots.ThoseshRNAsdonotreducethe
levels of the non-specific protein b-actin.
Chromatin immunoprecipitation
Lungs were dissected from CD1 mice (Charles River
Laboratories), minced and immediately immersed in 2 volumes
of 16PBS. For independent immunoprecipitations (IP), we
pooled ten E11.5 mouse lungs (n=2) or five E19.5 mouse lungs
Table 3. Human lung tumor data sets used in the correlation and GSEA studies.
GSEA p values
Set PMID
Number of
tumors Cell type E11.5/E11.5* E19.5/E18*
GSE12667 18948947 75 Adenocarcinoma 0.017 0.003
GSE10245 18486272 58 All ,0.001 ,0.001
40 Adenocarcinoma 0.432 0.044
18 Squamous 0.034 0.062
GSE10799 19208797 16 Adenocarcinoma 0.228 0.222
GSE10445 19176396 72 Adenocarcinoma 0.024 0.005
Bild 2006 16273092 111 All ,0.001 ,0.001
58 Adenocarcinoma ,0.001 ,0.001
53 Squamous ,0.001 ,0.001
GSE7670 17540040 27 Adenocarcinoma 0.124 0.821
Shedden DFCI 1 18641660 52 Adenocarcinoma ,0.001 0.118
Shedden DFCI 2 30 Adenocarcinoma 0.772 0.155
Shedden Moffitt 79 Adenocarcinoma 0.02 0.118
Shedden UMich 178 Adenocarcinoma 0.009 0.001
Shedden MSKCC 104 Adenocarcinoma 0.043 0.18
Lu U133A 17194181 18 Squamous 0.003 0.005
Bhattacharjee 2001 11707567 254 All 0.001 0.054
197 Adeno and Squamous only ,0.001 ,0.001
176 Adenocarcinoma 0.009 0.035
21 Squamous 0.063 0.002
Borczuk 2004 15087295 74 All 0.261 0.036
17 Adeno and Squamous only 0.592 0.183
10 Adenocarcinoma 0.457 0.626
7 Squamous 0.537 0.704
Lu U95Av2 17194181 36 All 0.771 0.125
32 Adeno and Squamous only 0.797 0.143
14 Adenocarcinoma 0.435 0.038
18 Squamous 0.961 0.717
Beer 2002 12118244 96 Adenocarcinoma 0.125 0.293
bold GSEA values ,0.05.
*Bound/Expressed.
doi:10.1371/journal.pone.0029907.t003
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tenth volume of fresh 11% formaldehyde solution, and incubated
for 10 minutes at room temperature. Formaldehyde was
quenched with 2.5 M glycine solution and tissues rinsed twice
in 16PBS. Crosslinked lung samples were flashed frozen in liquid
nitrogen and stored at 280uC. To solubilize and shear
crosslinked DNA, lungs were lysed and sonicated on ice in a
Branson Ultrasonic Sonicator coupled to a Fisher Scientific Sonic
dismembrator 500 power supply. Samples were sonicated at 90%
amplitude for 12 cycles of 30 second pulses with 60 second pause
between pulses, yielding fragments of about 500 bp. Part of the
whole cell extract was saved as input material and the rest was
incubated overnight at 4uC with 100 ml of Dynal Protein G
magnetic beads (Invitrogen) pre-incubated with 10 mlo ft h e
Nkx2-1 antibody (07-601, Upstate-Millipore) or IgG (Santa Cruz
Biotechnologies, Inc). Beads were washed 4–5 times with RIPA
buffer and 1 time with TE containing 50 mM NaCl. Bound
complexes were eluted from the beads by addition of elution
buffer and by heating at 65uC for 15 minutes with 2 minutes
interval of vortexing. Crosslinking in the IP and input samples
was reversed by overnight incubation at 65uC. Because Nkx2-1
null mice form only a lung rudiment due to impaired branching
morphogenesis we could not use those lungs as control in the
ChIP-chip experiments.
ChIP-chip sample preparation and hybridization
ChIP-chip experiments were performed as described previous-
ly [23]. Briefly, immunoprecipitated DNA (IP) and whole cell
extract DNA (input) were purified by treatment with RNAse A,
proteinase K and multiple phenol: chloroform: isoamyl alcohol
extractions. Purified DNA was blunt-ended and ligated to linkers,
and amplified using a two-stage PCR protocol. Amplified
immunoprecipitated DNA (IP) was labeled with Cy5 fluorophore,
and amplified whole cell extract DNA (input) with Cy3
fluorophore. Both IP and input were purified using Bioprime
random primer labeling kits (Invitrogen). Cy5 and Cy3 labeled
DNAs were mixed (,5 mg of each) and hybridized to arrays in
Agilent hybridization chambers for 40 hours at 40uC, washed
and immediately scanned.
Data Extraction, Normalization and Analysis
We used mouse promoter microarray sets (Agilent Technolo-
gies, AMADID: 014716 and 014717), consisting of 2 slides
containing ,244,000 60-mer oligonucleotides each, covering
,17,000 mouse genes 25.5 kb upstream to +2.5 kb downstream
from the transcriptional start sites. Replicate experiments were
performed for each time point and each array was scanned using
an Agilent scanner model G2565BA. The image analysis was
performed using Agilent’s Feature Extraction software v.9.5.3.1
set to the default ChIP protocol. To combine the replicates for
each time point, the raw data was background subtracted and
median normalized using limma library, part of the Bioconductor
project, in the R statistical environment [67,68]. The difference
of binding between the IP and Input (Cy5/Cy3), for each probe/
feature, was analyzed using empirical Bayes method implemented
in the limma package. P-values obtained from the multiple
comparison tests were corrected by false discovery rates. In
addition, for the binding profiles, we calculated average binding
ratio (Cy5/Cy3) for each probe by averaging the ratio between
the candidate bound probe and the 2 closest neighboring probes.
The complete data set is available at GEO Accession Number
GSE23043.
Table 4. Selected GO categories over-represented within developmental genes correlated to NKX2-1 levels.
GO Gene Symbols
E11.5 positive correlation
Cellular metabolism AASS AGPAT3 AHCYL1 APBB1 ASXL1 BCKDK CREBBP CRY2 CSTF3 CTSD CYB561 DDB1 DNAJC8 DPM2 EDF1 EIF4G1
ELAVL1 ENTPD4 EPC1 ERBB3 ERH ERO1LB FBXW5 FGFR3 FOXA1 FTS GNA11 GTF2H4 GUSB HADHB HERC2 HUWE1
KLF9 LONP METAP1 MLH1 MLLT3 MVK MXD4 MYBBP1A NEK6 NFIB NFYC NONO
Transcription APBB1 ASXL1 CREBBP EDF1 EPC1 FOXA1 GTF2H4 KLF9 MLLT3 MXD4 MYBBP1A NFIB NFYC NOTCH1 PHF13 POLR2C
RAB25 REST SMAD7 SMARCA5 SOX4 SP3 TCEB2 UBP1 UNR ZFP90 ZNF23 ZNF297
E11.5 negative correlation
GO Gene Symbols
Macromolecule metabolism ACVR2 AKR1A1 ALK ARIH1 BAG1 BAG2 BPGM CACYBP CCT3 CDC2 CHAF1B CLK3 CTSL2 DAG1 DNAJB11 DNAJC1
DNAJC10 EIF2B5 EIF5 ERO1L FKBP1A FLJ25059 FLT3 FURIN H2AFJ H2AFX ICT1 IDE ITM1 MAP3K11 MAPK1 MMP14
MRPL16 MRPL30 MRPL48 MRPS17 MRPS18A NDUFAF1 NEDD4 NEDD8 NSMCE1
Cell proliferation ANLN BCL2 BRRN1 CCNB1 CCNB2 CDC2 CDKN2C CHAF1B EMP1 FLT3 FTSJ3 GMNN KIF11 MAPK1 MCM2 MSH2
NR6A1 ORC2L PARD3 PAWR PRDX1 PSMD8 RBBP7 SMC2L1 SSBP1 TNFRSF7 UBE2C WARS
Cell death BAG1 BAG2 BCAP31 BCL2 BNIP2 DAD1 DAP3 EI24 EMP1 LIMS1 MAPK1 PAWR SEMA4D TNFRSF7 TUBB TXNL1
E19.5 positive correlation
GO Gene Symbols
Signal transduction ABR ADCY7 ADRB2 ANK3 ARRB1 ATM CLOCK DPYSL3 ENPP2 EPS8 GNA11 IL1R1 IRS1 LY6E NFKBIA NRP1 PKD1
PRKCZ RAB17 RAB24 RAC1 RASGRF1 RGL2 SCGB1A1 TM4SF6 TOLLIP VAPA
E19.5 negative correlation
GO Gene Symbols
Catabolism ADAM17 ANAPC5 BLMH CASP3 CTSB DDX1 DNPEP DPEP1 F7 G6PD GLUD1 PAFAH1B3 PDHA1 PSMD8 PYGB UBE2L3
GO level $4; Bayes Factor $0; p#0.03; number of genes$10.
doi:10.1371/journal.pone.0029907.t004
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Probes at E11.5 and at E19.5 with p#0.001 and log2 binding
ratio $0.75 were selected to query the Expression Analysis
Systematic Explorer (EASE) to discover enriched biological
themes within the probe sets [29]. Multiple probes within a probe
set representing binding to the same gene were consolidated by
selection of the probe with the highest fold difference (correspond-
ing to the peak of the binding region). Using median stringency
settings we identified overrepresented functional annotation
clusters (p#0.05) for each list. We performed pathway enrichment
analyses by using Ingenuity database through IPA interface.
Enriched canonical pathways at significance level of p#0.05 were
compared between time points.
Correlation analyses
A list of 374 unique mouse gene symbols corresponding to genes
both bound by Nkx2-1 and expressed in E11.5 mouse lung
epithelium was obtained by intersecting a list of 1362 unique gene
symbols corresponding to significant Nkx2-1 binding peaks at day
E11.5 (Dataset S1) and a list of genes called present (detection p
value#0.05) inallmeasurementsin a microarray analysis ofisolated
lung epithelium at day E11.5 [26], processed in Affymetrix, MG-
U74v2 set and Microarray Suite 5 (MAS5). Gene symbols were
translated to 350 unique mouse Entrez Gene IDs using a table
obtained from the Homologene resource at NCBI (http://www.
ncbi.nlm.nih.gov/sites/entrez?db=homologene).
A list of 183 unique mouse gene symbols corresponding to
genes both bound by Nkx2-1 at E19.5 and expressed in E18
mouse lung was obtained by intersecting a list of 1358 unique
gene symbols corresponding to significant Nkx2-1 binding peaks
at day E19.5 (Dataset S1), translated to mouse Entrez Gene IDs
using the Homologene table, and 2611 unique Entrez Gene IDs
called present in all measurements in E18 lung, obtained from
GEO series GSE10889 [27], processed with MAS5 and
normalized with mouse Entrez Gene-specific CDF. All mouse
Entrez Gene IDs in both gene sets were then translated to the
Entrez Gene IDs of their human homologues using the
Homologene table.
The human lung tumor data sets used in this study were identified
in a search of the literature and the Gene Expression Omnibus
(GEO) for microarray expression profiles of primary lung adenocar-
cinomas and squamous carcinomas (Table3).The search was limited
to include only those experiments performed using Affymetrix
microarray platforms and for which raw CEL files were publicly
available. Gene-specific expression levels were obtained using the
Robust Multiarray Average (RMA) [68] and a Chip Definition File
(CDF) that collapses oligonucleotide probes to probesets correspond-
ing to Entrez Gene IDs [69], obtained from http://brainarray.mbni.
med.umich.edu/Brainarray/Database/CustomCDF/). All compu-
tations were performed in R (version 2.9.2). To correlate expression
of Nkx2-1 target genes to the levels of Nkx2-1, the 350 human
homologues at E11.5 and the 183 at E19.5 were ranked according to
the absolute value of the Pearson correlation coefficient of its
expression level and that of NKX2-1, withineachhuman lung tumor
dataset. GSEA was then performed to determine whether the genes
in the E11.5 and E19.5 gene sets were significantly enriched toward
the top of each ranked list. A total of 1000 random permutations were
usedtodeterminesignificanceineachGSEAanalysis.Thoseanalyses
for which no permutations had greater significance than the gene set
being tested are denoted as p,0.001. To elucidate biological
signatures from the developmental genes correlated or anti-correlated
with NKX2-1 levels in human lung tumors we used GATHER tool
[70].
Lentivirus production and cell transduction
Mouse lung epithelial MLE 15 cells (a gift of Dr. Jeffrey A.
Whitsett, Cincinnati Children’s Hospital Medical Center) were
cultured in modified conditions as described previously [71], and
transduced with lentivirus expressing shRNAs targeting mouse
and human Nkx2-1 as we described previously [63]. We used
individual clones TRCN0000020449, TRCN0000020450, and
TRCN0000086264 contained in shRNA sets RHS4533 and
RMM4534 (Open Biosystems). Lentivirus empty vector
(RHS4080, Open Biosystems) was used as non-silencing control.
ChIP-PCR, ChIP-qPCR and qRT-PCR
E11.5 and E19.5 immunoprecipitated lung DNA (IP) using the
Nkx2-1 antibody (07-601, Upstate-Millipore) or its corresponding
IgG (Santa Cruz Biotechnologies), the input material and genomic
DNA were analyzed by PCR, or by qPCR in a StepOnePlus
(Applied Biosystems). Using equal amount of DNA from each
sample, we performed PCR using polymerase (Qiagen) and
primers for various selected targets of Nkx2-1 listed in Table S7.
qPCR was performed using SYBR Green (Applied Biosystems).
For expression analyses, isolated RNA (1 mg) was reverse
transcribed (RT) using TaqMan reverse transcription reagents
(Applied Biosystems) and Taqman assays on demand and Taqman
Master Mix (Applied Biosystems) [63].
Cell proliferation analyses
For cell cycle analysis by FACS, MLE15 cells transduced with
Nkx2-1 shRNA or non silencing vector were harvested, washed
twice with 1XPBS, and re-suspended in 500 ml 1XPBS, at 4uC.
Ice-cold ethanol (5 ml) was added drop-wise to the cell suspension
and incubated overnight at 220uC. Cells were stained in 1 ml
propidium iodide (PI) solution (1XPBS +50 mg/ml PI +100 mg/ml
RNAse A), filtered using a 40 mM filter (BD Biosciences) and
incubated at 4uC in the dark for 20 minutes before analyzing them
by flow cytometry (BD FACScan; BD Biosciences, and FlowJo
analysis software, Treestar).
Cell growth was measured by counting cell numbers of MLE15
cells transduced with Nkx2-1 shRNA or non silencing vector at
24 hours intervals for 4 days. We initiated the cultures seeding
5000 cells in triplicate. Cultured cells were trypsinized at 24, 48, 72
and 96 hours resuspended in equal volume of media and counted
using a Scepter handheld automated cell counter (Millipore).
Western Blot Analyses
Mouse lungs and thyroid were dissected and homogenized in
1 ml of RIPA buffer (50 mM Hepes (pH 7.6), 1 mM EDTA, 0.7%
Na deoxycholate, 1% NP-40, 0.5 M LiCl) plus Complete Protease
Inhibitor Cocktail (Roche) and incubated in a rotator at 4uC for
2 hours. MLE15 and E10 mouse cells, and H441 and H661
human cells, grown in 10-cm diameter plates, were washed twice
with 1XPBS, resuspended in 1 ml of RIPA buffer plus complete
protease inhibitors cocktail and lysed by gentle vortexing
every 5 minutes for 30 minutes. Samples were centrifuged at
14,000 rpm for 15 minutes, and the supernatant was collected and
used in western blot analyses. Thirty micrograms of protein were
electrophoresed in 12.5% Hydro Colorize gels (Bio-Rad) and
electro-transferred to Immobilon-P Transfer membranes (Milli-
pore). Proteins were detected with the Nkx2-1 antibody (07-601,
EMD-Millipore-Upstate-), the Nkx2-1 antibody (ab76013; Ab-
cam), b-Actin [63], and/or Gapdh (G9545, Sigma-Aldrich) and
their corresponding secondary antibodies, in a LAS-4000
chemiluminescence image analyzer (Fuji). To compare the signals
obtained by these antibodies and previously published western
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antibody (Thermo Fisher Scientific) following the manufacturer
protocols. Data are shown in Supplementary Figure S5. Similar
bands are detected between 40 and 50 kDa with the 07-601 rabbit
polyclonal and the 8G7G3/1 mouse monoclonal antibodies. The
ab76013rabbit monoclonal antibody only detects one band in that
range.
Immunohistochemistry
E11.5 whole embryos and E19.5 dissected lungs were fixed in
freshly prepared 4% paraformaldehyde in 1XPBS, pH 7.4, at 4uC
for 16 hours. For immunohistochemistry, tissues were embedded
in paraffin following standard processing with ethanol dehydra-
tion. Tissue sections (6 mm) were deparaffinized and hydrated by
standard methods. Antigen retrieval was done using an Antigen
Unmasking solution (Vector Laboratories). Endogenous peroxi-
dase was quenched with 3% H2O2 in methanol for 15 minutes.
Blocking was performed with 2% normal goat serum in 1XPBS at
room temperature for 1 hour. The tissues were incubated with the
Nkx2-1 antibody (ab76013, Abcam, 1:500) at 4uC for 16 hours,
and then washed with 1XPBS (5 minutes, twice). Antibody
binding was detected with the Vectastain Elite ABC kit (Vector
Laboratories) and diaminobenzidine (DAB) as substrate. Images
were taken using Leitz Aristoplan microscope. For immunofluo-
rescence, tissues were washed in 1XPBS for 30 minutes,
dehydrated in 7.5% sucrose/1XPBS, pH7.4 for 1 hour and then
30% sucrose/1XPBS, pH 7.4 at 4uC for 16 hours. They were
then embedded with optimal cutting temperature (OCT) medium
in tetra-fluoro-ethane (TFE), liquefied in liquid nitrogen. Sections
(6 mm) of these tissues were washed with 1XPBS (5 minutes,
twice), blocked in 0.5% goat serum in PBS (1 hour) and incubated
for 16 hours at 4uC with a mixture of Nkx2-1 antibodies
[(ab76013, Abcam, 1:500) or (07-601, Upstate-Millipore, 1:500)]
and mouse anti-human Ki67 antibody (550609, BD Biosciences,
1:250). They were washed with PBS (5 minutes, twice), incubated
with M.O.M.
TM Biotinylated Anti-Mouse IgG Reagent (FMK-
2201, Vector Laboratories, 1:200) for 30 minutes, washed with
PBS (5 minutes, twice), and exposed to a mixture of Alexafluor
488 goat anti rabbit IgG (H+L) (A11008, Invitrogen, 1:200) and
Streptavidin conjugated Cy3 at (43-4315, Invitrogen, 1:2000) for
another 30 minutes. After washing in PBS (5 minutes, twice), the
sections were air dried and cover slipped with Prolong Gold
(P36935, Invitrogen). Images were taken using the LSM 510
Axiovert 200 M.
Supporting Information
Figure S1 Genome-wide patterns of Nkx2-1 binding.
Location of Nkx2-1 binding in all mouse chromosomes in E11.5
(red) and E19.5 (green) lungs. X axis (chromosomal location), y
axis (binding signal intensity).
(TIF)
Figure S2 Nkx2-1 binding patterns to selected target
genes in lung development. Binding profiles of Nkx2-1 to
newly identified target genes (left panel). Chromatin immunopre-
cipitation-qPCR validation of Nkx2-1 binding to target genes (right
panel). IP DNA from E11.5 and E19.5 lungs, input and IgG
immunoprecipitated control were used in qPCR analyses. Oligo-
nucleotides in the promoter region were used to analyze binding of
Nkx2-1, (n=3). Data are expressed relative to the input.
(TIF)
Figure S3 Relative expression of selected Nkx2-1 target
genes in E12 and E18 developing mouse lung extracted
from the expression microarray dataset GEO series GSE
10889 (27).
(TIF)
Figure S4 Nkx2-1 levels in human lung tumors signifi-
cantly correlate with expression of developmental Nkx2-
1 target genes. Additional heatmaps of human lung tumor genes
identified in GSE 12667 dataset showing gene expression levels of
the human homologues of Nkx2-1 target genes identified in mouse
lung development at E11.5 (upper panel) and E19.5 (lower panel);
genes are organized in the same order as in Figure 4, according to
the Pearson correlation value (y axis) to NKX2-1 expression (x axis).
(TIF)
Figure S5 Comparison of three commercial Nkx2-1
antibodies. Western blot experiments were performed using
MLE15 lung epithelial cell protein extracts. Nkx2-1 rabbit
polyclonal antibody (EMD-Millipore-Upstate), rabbit monoclonal
antibody (Abcam) and mouse monoclonal antibody (LabVision,
Fisher Scientific) detect a strong band between 40–45 kD (upper
black arrow). Bands of lower intensity are detected around 40 kD
with the rabbit polyclonal and the mouse monoclonal antibodies
(lower black arrow). Other bands of minor intensity are detected
(*) but their identity is unknown. The mouse IgG light chain is
detected using the mouse monoclonal antibody (**).
(TIF)
Table S1 (a). Target genes at E11.5 (log(2) .0.75, p#0.001). (b)
Target genes at E19.5 (log(2) .0.75, p#0.001).
(DOC)
Table S2 Nkx2-1 target genes expressed in lung development
and correlated to NKX2-1 levels in human lung tumor datasets.
(DOC)
Table S3 Genes bound and regulated by Nkx2-1 in human fetal
lung epithelial cells.
(DOC)
Table S4 (a) E11.5 overrepresented biological processes identi-
fied by EASE analysis p,0.05. (b) E19.5 overrepresented
biological processes identified by EASE analysis (p,0.05).
(DOC)
Table S5 Overrepresented canonical pathways identified by
Ingenuity Pathway Analysis Software.
(DOC)
Table S6 Nkx2-1 target genes genes included in Cancer
pathways identified by IPA.
(DOC)
Table S7 PCR and qPCR Oligonucleotide sequences.
(DOC)
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